跳至主要内容
临床试验/NCT02246790
NCT02246790Unknown3 期

Surgical Ablation of Long-standing Persistent Atrial Fibrillation During CABG Through Continuous Subcutaneous Monitoring

Meshalkin Research Institute of Pathology of Circulation1 个研究点 分布在 1 个国家目标入组 116 人开始时间: 2014年12月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
发起方
入组人数
116
试验地点
1
主要终点
Freedom from atrial fibrillation

研究概览

简要总结

Purpose. Comparison of outcomes in patients underwent CABG combined with left atrial and biatrial radiofrequency ablation of long-standing persistent atrial fibrillation.

Hypothesis of the study - patients with long-standing persistent atrial fibrillation and coronary artery disease after CABG in combination with biatrial RFA have a better outcomes for the freedom of AF compared with patients undergoing left atrial RFA during CABG.

详细描述

This is a single blinded prospective randomized study involving 116 patients with long-standing persistent AF and coronary artery disease. 116 patients are required to have a 80% chance of detecting, as significant at the 5% level, an increase in the primary outcome (freedom fro AF) measure by 12% in the biatrial group over left atrial group. Patients are divided into two groups, group I - biatrial + CABG (58 patients), and group II - left atrial + CABG (58 patients). Randomization is conducted by using accidental sampling before operation. The blinding process is applied to a patient, who is informed about received coronary artery bypass grafting, but don't know about kind of surgical ablation. Subcutaneous cardiac monitor is implanted to all patients for cardiac rhythm monitoring.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •American College of Cardiology (ACC)/ American Heart Association (AHA) Indications for CABG
  • •At least 2 ECG-verified (12-channel ECG, Holter telemetry) long-term persistent AF within last 12 months
  • •The patient's consent to participate in the study

排除标准

  • •Intolerance of antiarrhythmic drugs
  • •Heart valve disease requiring invasive treatment
  • •Left atria more than 6.5 cm
  • •Prior cardiac surgery
  • •Active pacemaker treatment
  • •Active anti-arrhythmic treatment (AAD) class I and III
  • •Contraindication to oral anticoagulant/heparin treatment
  • •Ejection fraction less than 30 % (EF < 30 %) assessed by transthoracic echocardiography

研究组 & 干预措施

Biatrial radiofrequency ablation and CABG

Active Comparator

Biatrial radiofrequency ablation during CABG

干预措施: Biatrial radiofrequency ablation and CABG (Procedure)

Left atrial radiofrequency ablation and CABG

Active Comparator

Left atrial radiofrequency ablation during CABG

干预措施: Left atrial radiofrequency ablation and CABG (Procedure)

结局指标

主要结局

Freedom from atrial fibrillation

时间窗: up to 36 months

Freedom from AF. All cases of AF after surgical intervention. Atrial fibrillation is defined as atrial fibrillation paroxysm lasting at least 60 seconds. Patients with AF\>0.5% were classified as non-responders.

次要结局

  • Cardiovascular events(Within three years after surgery)

研究者

发起方
Meshalkin Research Institute of Pathology of Circulation
申办方类型
Network
责任方
Principal Investigator
主要研究者

Alexander Romanov

Meshalkin Research Institute of Pathology of Circulation

Meshalkin Research Institute of Pathology of Circulation

研究点 (1)

Loading locations...

相似试验